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THE data reported in the preceding communication (Harper, 1959) have led to
the conclusion that the only important difference between the metabolisms of
carcinogenic and non-carcinogenic hydrocarbons lies in the positions of the
molecule at which hydroxylation initially occurs. Two possible explanations
of this difference were considered to be:
(a) That the reactive centres of carcinogenic hydrocarbons are initially
blocked by cellular material;
or
(b) that different mechanisms of hydroxylation are operative during
the metabolism of carcinogenic and non-carcinogenic hydrocarbons
respectively.
The mechanism of aromatic hydroxylation is a subject which has received
much attention in recent years but so far the investigations have been confined
to only two members of the polycyclic hydrocarbon series, namely, naphthalene
and 3: 4-benzpyrene. Fortunately for the purpose of this discussion, however,
these may be regarded as typical members of the non-carcinogenic and carcino-
genic hydrocarbons respectively.
It was first shown by Mitoma, Posner, Reitz and Udenfriend (1956) that
an enzyme system capable of hydroxylating a variety of organic compounds
was able to effect the in vitro conversion of naphthalene into 1-naphthol (but not
2-naphthol) and a dihydrodiol-like compound which yielded 1-naphthol on acid
hydrolysis. The system was located in the microsomal fraction of liver homo-
genate (but not of brain, kidney, lung and muscle) and required reduced tri-
phosphopyridine nucleotide and oxygen for activity.
A similar enzyme system was found by Conny, Miller and Miller (1957) to
effect the hydroxylation of 3: 4-benzpyrene and the products thus obtained were
identical to those yielded during in vivo metabolism of the hydrocarbon. The
"hydroxylase" was similarly located in the liver microsomes and, although both
reduced tri- and diphosphopyridine nucleotides (TPNH and DPNH) and oxygen
were required for maximal activity, high activity was supported by TPNH and
oxygen alone. The system differed from that of Mitoma et al. (1956) however
in not being inhibited by the metal binding compounds a, a'-dipyridyl and
o-phenanthroline.
Further investigation of the naphthalene hydroxylating system by Booth
and Boyland (1957, 1958) confirmed the findings of Mitoma et al. with respect
to the cellular distribution and requirements of the system but it was foundMETABOLISM, CELLULAR BINDING AND CARCINOGENESIS
that neither a, a'-dipyridyl nor o-phenanthroline inhibited activity to any
great extent. Also, in like manner to the benzpyrene hydroxylating system,
inhibition was not observed with either cyanide or cysteine but strong inhibition
occurred in the presence of p-chloromercuribenzoate suggesting the involvement
ofsulphydryl groups.
On this evidence therefore it appears probable that the same enzyme, or
closely related enzymes with the same co-enzyme requirements, are responsible
for the hydroxylation of naphthalene, a non-carcinogen, and 3: 4-benzpyrene, a.
potent carcinogen. If such is the case it is unlikely that such closely related
systems operate by different mechanisms.
This brings us back to the alternative possibility therefore, of an initial
blocking of the reactive centres of the carcinogen by cellular material. The
problem in this case is to determine at what region of the molecule such binding
is likely to occur, for reference to Table II of the preceding communication
(Harper, 1959) reveals the presence of both reactive carbon atoms and reactive
bonds although these coincide in certain cases.
The possibility of binding across reactive non-adjacent carbon atoms was
considered by Dickens and Weil-Malherbe (1946) who compared metabolic
hydroxylation with the chemical method used most successfully in the synthesis
of certain metabolic phenols, i.e. sulphonation of the meso-quinone followed by
reduction and alkali fusion. An attempted synthesis of 8-benzpyrenol starting
with the 5: 10-quinone was unsuccessful owing to failure at the reduction stage
but none the less Dickens and Weil-Malherbe considered that this chemical
evidence tallies well with the conception that the most reactive centres of the
hydrocarbon molecule are blocked with a cellular constituent and that oxidation
then occurs at the most reactive centres remaining.
The other possibility of binding at the reactive bond of the hydrocarbon was.
proposed by Boyland (1948, 1950a) and a similar conclusion concerning the
formation of 3-chrysenol from chrysene was arrived at by Berenblum and
Schoental (1949). The reactive bond corresponds, in most cases, to the so-called
K-region of the molecule and great significance is attached to this proposal when
considered in relation to the evidence obtained by the Heidelberger school on
the binding of hydrocarbons to protein within the skin. In the case of one
hydrocarbon, 1: 2: 5: 6-dibenzanthracene, it has actually been established that
about 25 per cent ofthe bound total is attached through both mono- and di-amido
linkages in one K-region (Bhargava and Heidelberger, 1956) so that here is
experimental evidence in support of the Boyland hypothesis.
A theoretical treatment of this problem by Pullman and Pullman (1955)
was based upon the somewhat arbitrary assumption that the hydrocarbon,
bound through its K-region, then exists in an ortho-quinonoidal configuration.
In the example selected, 1: 2-benzanthracene, it was calculated that the reactive
centre of the hydrocarbon bound in this way then resides on the 3' carbon atom
and not the metabolic 4' position. This difficulty was overcome by postulating
the formation of an epoxide across the 3'-4' bond which then undergoes hydro-
lysis under enzymatic control to yield the 3'-4' dihydrodiol. Finally the
elements of water are split offleaving the hydroxyl group in the 4' position.
Despite the obvious limitations of such a hypothetical treatment it will be
seen that both these proposals, one involving a para and the other an ortho
form of binding, are unable in themselves to account for the formation of more-K. H. HARPER
than one phenol from the same hydrocarbon. Indeed, the mechanism proposed
by Pullman and Pullman (1955) leads to the formation of the same phenol as
that obtained from the para-quinone by the described chemical synthesis.




















FIG. 1.-Phenolic metabolites of the polycyclic hydrocarbons.
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these can be classified on the basis of the structural relationship they bear to one
another into two distinct groups designated as A and B in the diagram. What
is proposed by the author therefore is that the hydrocarbon may undergo both
ortho and para forms of binding during hydroxylation and that in these two
states different secondary positions of the molecule become activated. Such a
proposal is not entirely speculative for only 25 per cent of the total bound
1: 2: 5: 6-dibenzanthracene could be accounted for by binding in the K-region
(Bharagava and Heidelberger, 1956). The remaining 75 per cent is presumably
bound at some other region of the molecule. Also 1: 2: 3: 4-dibenzanthracene
does not possess an active K-region and yet is bound to an even greater extent
than the 1 : 2: 5: 6-isomer (Heidelberger and Moldenhauer, 1956). In this case
evidence of binding in the reactive meso-positions has in fact been obtained
(Oliverio and Heidelberger, 1958).
The essential problem then is to determine which form ofbinding is responsible
for the formation of Group A phenols and which form for Group B. For this
purpose the effect of both forms of binding will be considered in relation to the
products yielded by individual hydrocarbons. As the exact mode of binding
is as yet unknown the hydrocarbon will be assumed to form an addition type of
complex as proposed by Boyland (1950a). In such compounds the nuclear
bond system is that ofthe ortho- or para-quinone although there is little contribu-
tion of the bond linkages to the resonance energy of the system. Should the
binding prove to be of a different nature however, it is anticipated that similar
considerations will apply.
1 : 2: 5: 6-Dibenzanthracene
Three phenolic metabolites of this hydrocarbon have now been identified,
the 4': 8'-dihydroxy derivative from the rat and mouse (Cason and Fieser,
1940) and the 2'-hydroxy and 2': 6'-dihydroxy derivatives from the rabbit
(Labudde and Heidelberger, 1958). In this instance where the molecule is
symmetrical about a central axis, it is to be anticipated that binding across




(cf. the sulphonation of 1: 2: 5: 6-dibenz-9: 10-anthraquinone). Monohydroxy-
lation would not therefore be expected. If on the other hand, binding were to
occur at one of the two K-regions (II) then in this instance, where the activating
group is asymmetrically situated, it is unlikely that two positions ofthe molecule
would become activated to the same extent. Consequently the formation of a
monohydroxylated derivative only would be favoured. In the event of binding
at both K-regions, however, the activation in both halves of the molecule would
then be equal and dihydroxylation would most probably take place.
It will be seen therefore that the formation ofboth mono- and di-hydroxylated
products in the rabbit is best explained on the basis of an ortho form of binding
at one and both K-regions respectively. Conversely the formation of a di-
hydroxylated-but not a monohydroxylated-derivative in the rat and mouse
is consistent with a para form of binding across the reactive meso-positions. The
inference is therefore that species differences in metabolism are due to differences
in the region of the molecule at which linkage to cellular material occurs during
hydroxylation in these species. If this reasoning is correct an ortho form of
binding would appear to be favoured in the rabbit and a para form in the rat and
mouse. The question immediately arises, however, as to why the mouse does
not yield a mixture of phenolic metabolites for K-region binding in this species
is now an experimentally established fact. One obvious answer is that the
2'- and 2': 6'-hydroxylated compounds are formed but in amounts so small
that they have so far escaped detection. This behaviour would then fall into
line with that of 3: 4-benzpyrene for which only a quantitative difference in
metabolism has been reported (see later). A possible explanation of this is
that the bound complex II behaves as a 2: 3-disubstituted phenanthrene
derivative and as such is particularly susceptible to oxidation at the reactive
9-10 bond, corresponding to the 7-8 bond of dibenzanthracene. Consistent with
this hypothesis is the formation within the tissues of the 3: 4-quinone
(Heidelberger, Hadler and Wolf, 1953) and 2-phenylphenanthrene-3: 2'-
dicarboxylic acid (Bhargava, Hadler and Heidelberger, 1955).
1: 2-Benzanthracene
IV V
Application of this reasoning to 1: 2-benzanthracene leads to the conclusion
that, by analogy, the 4'-hydroxy metabolite, a Group A phenol, is formed as a
result of binding across the reactive meso-positions (IV). The formation of
2'-hydroxy-1: 2-benzanthracene is therefore to be anticipated as a consequence
of binding in the K-region (V) and it is significant that the evidence reported in
the preceding publication is consistent with the formation of an additional
phenolic metabolite. It would obviously be of great interest to determine the
major site of metabolism in the rabbit where, according to theory, a K-region
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binding of hydroxylation is favoured. Investigations are already in hand to
test this proposal.
3: 4-Benzpyrene
The formation of six different phenolic metabolites from 3: 4-benzpyrene
has now been reported, 5-benzpyrenol (Pihar and Spaleney, 1956), 8-benzpyrenol
(Berenblum, Crowfoot, Holiday and Schoental, 1943), 10-benzpyrenol (Berenblum
and Schoental, 1946), 5: 8- and 5: 10-dihydroxy-benzpyrenes (Conney et al.,
1957) and an unidentified phenol designated as the F1 metabolite (Weigert and





The ease with which 3 : 4-benzpyrene undergoes oxidation to a mixture of
5: 8-, 5: 10-, and possibly 6: 7-quinones (Cook and Schoental, 1950) suggests
that the molecule readily assumes the nuclear bond structures VI-VIII. It
is possible then that binding may occur across the 5: 8-, 5: 10-, and 6: 7- (K-
region) positions of the molecule, each of which leads to the formation of a
different phenol. By analogy with 1: 2: 5 : 6-dibenzanthracene an ortho form
of binding in the K-region (VI) may be expected to activate the 10-position and
it is significant that 10-benzpyrenol, a Group B phenol, is formed to a greater
extent in the rabbit than in the rat and mouse (Berenblum and Schoental, 1946).
As the para configuration of structure VII is analogous to that of a true
meso-quinone it is then possible that binding across the 5,10 positions would
result in activation of the 8-position (Group A). By elimination, formation of
the F1 metabolite may then be attributed to binding in the 5,8 positions.
An alternative treatment, however, is to regard the K-region bound structure
VI as a 6: 7-disubstituted chrysene. On this interpretation position 2 of the
chrysene molecule, corresponding to the 1-position of benzpyrene, would be
expected to be most active and indeed may be expected to represent a major
site of hydroxylation. It is possible therefore that the F1 derivative is 1-
benzpyrenol and consistent with this hypothesis is the fact that F1 is undoubtedly
51
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the major product of hydroxylation during the first few hours following injection
of 3: 4-benzpyrene (Weigert and Mottram, 1946; Harper, 1958).
If structure VI does in fact exhibit the normal chemical reactivity of chrysene
a further stage of binding may occur at the reactive 1-2 bond (IX) and, by
analogy with chrysene (see later), lead to the formation of 10-benzpyrenol.
IX
The other phenolic metabolites of benzpyrene, 5-benzpyrenol and the 5: 8-
and 5: 10-dihydroxy derivatives, differ from the others so far considered in that
hydroxyl groups have entered the molecule in the chemically reactive positions.
A possible explanation ofthis is that hydroxylation may occur to a certain extent
when the hydrocarbon is in an unbound state. Perhaps significantly the latter
compounds have only been detected in in vitro studies with the isolated micro-
somal system in which the normal in vivo pattern of cellular binding may not
prevail to the same extent.
Chrysene
The hydroxylation ofchrysene is more difficult to interpret for the 3-chrysenol
rat metabolite (Berenblum and Schoental, 1949) may be regarded as either a
Group A or Group B phenol. By analogy with other hydrocarbons an ortho
form of binding in the K-region (X) must be favoured in this instance. A para
form of binding across the reactive 2,8 positions (XI) on the other hand may be
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The two possible modes of binding for 20-methylcholanthrene are shown in
XII and XIII. By analogy with other hydrocarbons these may be expected
to activate the 2 and 4 positions respectively. The ortho bound structure,
XII, however, may be regarded as a disubstituted acenaphthene derivative aind
as such would be more prone to oxidation at the 15-16 bond of the pentacyclic
ring (cf. the metabolism of acenaphthene, Chang and Young, 1943). The
evidence reported in the preceding paper suggests that this does not occur to
any appreciable extent and a para form of binding (XIII) across the 11, 14
positions is therefore favoured. A possible structure for the phenolic metabolite
isolated in that work is therefore 4-hydroxy-20-methylcholanthrene.
So far these theoretical considerations have been confined to the carcinogenic
members of the polycyclic hydrocarbons. As was pointed out in the preceding
publication (Harper, 1959) the products obtained from non-carcinogenic hydro-
carbons are consistent with the view that hydroxylation occurs at the most
reactive positions of the molecule and perhydroxylation at the most reactive
bonds although the perhydroxylation of phenanthrene at the 1-2 bond in the
rabbit is an obvious exception to this generalisation. This behaviour may be
interpreted as indicating that the non-carcinogenic members are metabolised
primarily when in an unbound state and would be in accordance with the conclu-
sion of Heidelberger and Moldenhauer (1956) that non-carcinogenic hydrocarbons
do not undergo binding to protein to any appreciable extent. The evidence of
Hadler, Darchun and Lee (1957), however, would suggest that the non-carcinogens
may go through a transient protein-bound phase of at least the same order of
magnitude as that observed with the carcinogens. The findings of Calcutt (1958)
are not only consistent with this view but also show that ,binding may occur in
other tissues apart from the skin. It is of interest therefore to speculate upon
the effects of ortho and para forms of binding on the reactivities of this class of
compounds.
Naphthalene
xlv xv XI1V XV
A variety of hydroxylated products, 1- and 2-naphthol (Bourne and Young,
1934; Corner and Young, 1954, 1955), 1: 2-dihydroxy-naphthalene (Corner and
Young, 1954, 1955), 1: 2-dihydroxy-1: 2-dihydro-naphthalene (Young, 1947)
and 1-hydroxy-l:2-dihydro-naphthalene (Boyland and Solomon, 1955) are
formed during the metabolism of this hydrocarbon. In all cases, however,
attack is at the 1-2 bond and any form of binding must therefore activate this
region of the molecule.
The two possible modes of binding for naphthalene are shown in XIV and
XV. It is highly improbable that either of these lead to activation in the
unsaturated benzene ring and the only possible means of activation of the







Unlike naphthalene the reactive carbon atoms of anthracene do not coincide
with the reactive bond. If, as concluded earlier, hydroxylation of the un-
bound hydrocarbon occurs at the reactive positions of the molecule then the
derivative 9: 10-dihydroxyanthracene (or 9: 10-anthraquinone) is to be anti-
cipated as a result of this process. There is in fact evidence that the 9:10-
quinone is excreted as a metabolite of anthracene in the urine (Boyland and
Levi, 1936) although the possibility of this being present as an impurity in the
administered hydrocarbon was not discounted in that work. Since then however
it has been reported that administered 9: 10-anthraquinone is itself subjected
to hydroxylation (Sato, Fukuyama, Yamada and Suzuki, 1956) so that the
quinone isolated by Boyland and Levi was probably a true product ofhydroxyla-
tion and not due to impurity. The major point of attack, however, is at the
1-2 bond resulting in the formation of 1: 2-dihydroxy-1: 2-dihydro-anthracene
(Boyland and Levi, 1935). What must be decided, therefore, is whether the
ortho or para bound structures (XVI and XVII) above-are characterised by any
marked reactivity at the 1-2 bond.
Unfortunately little is known of the reactivity of the 1,2 addition compounds
although the fact that the perhydroxylation of anthracene with Criegie's reagent
(Cook and Schoental, 1948) leads to the formation ofthe 1: 2: 3: 4-tetrahydroxy-
1 : 2: 3: 4-tetrahydro derivative (XVIII) and not the 1: 2-dihydrodiol (XIX)
suggests that marked activation of the 3-4 bond may occur, assuming the course
of the reaction to be as shown.
I -. N. .
XIX XVIII
The process ofpara-blocking in the 9,10 position, however, as with hydrogena-
tion and quinone formation, leads to the formation of particularly stable
compounds in which the reactivity of the molecule as a whole is greatly reduced
by comparison with that of anthracene. Addition at these points therefore is
to be regarded as a deactivating rather than activating mechanism.
An ortho form of binding (XVI), as proposed by Boyland and Wolf (1950),
is therefore favoured in this instance although the alternative para form is not
entirely discounted.
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Phenanthrene
Phenanthrene is the sole non-carcinogenic hydrocarbon for which a species
difference in the site of hydroxylation has been reported, the 9: 10-dihydrodiol
being formed in the rat and mouse and a mixture of the 9: 10- and 1 : 2-
dihydrodiols in the rabbit (Boyland and Wolf, 1948, 1950). The fact that the
carbon atoms comprising the highly reactive 9-10 bond are themselves the
reactive positions makes it unlikely that perhydroxylation at this bond is due
to binding at some other region of the molecule.
xx
The additional formation of the 1: 2-dihydrodiol in the rabbit, however,
may be attributed to binding across the reactive 9-10 bond (XX), as proposed
by Boyland and Wolf (1950), and provides further support for the suggestion
that an ortho form of binding is favoured in the rabbit. The fact that 9:10-
dihydrophenanthrene undergoes Friedel and Crafts' acylation exclusively in the
2-position is evidence that such addition may have a directive influence.
To summarise these proposals, therefore, it can be said that the metabolism
of non-carcinogenic hydrocarbons is best explained on the assumption that
hydroxylation occurs when they are either in a free state or bound to cellular
material through their most reactive bond. The metabolism of carcinogenic
members on the other hand would suggest that hydroxylation occurs principally
after binding and the formation of different phenols from the same hydrocarbon
is then explainable if it is postulated that binding may occur either at the
reactive bond or reactive positions of the molecule. On such reasoning it is
tentatively concluded that species differences in the site of hydroxylation are
due to differences in the relative contributions of these distinct forms of binding
to the total amount bound in any one species. An ortho form of binding at the
reactive bond would appear to be favoured in the rabbit and a para form across
the reactive positions in the rat and mouse.
A critical test of these proposals is the verification that the reactive centres
of the ortho and para addition products, or perhaps those of the derived ortho-
and para-quinonoidal configurations, do in fact correspond to those attacked
during metabolism. Furthermore, as the binding data referred to in this discus-
sion has been obtained from skin, not only must it be established that the same
system of microsomal hydroxylation is operative within this tissue but also that
the hydrocarbon is actually subjected to binding during hydroxylation in the
system. There is evidence in fact that the latter condition is attained, for it
was found by Conney et al. (1957) that mild alkaline hydrolysis (methanolic
potassium hydroxide at 3° C. for 24 to 48 hours) was necessary for the quantita-
tive liberation of 3: 4-benzpyrene after addition to the in vitro hydroxylating
system. Further investigation is obviously required to establish this point and
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other limitations will doubtless be exposed when metabolic studies are extended
to other hydrocarbons and other species. The proposals are not put forward in
any dogmatic sense, therefore, but as a possible explanation of certain known
facts concerning the biochemical hydroxylation of polycyclic hydrocarbons, an
explanation which may be checked by direct experimentation.
The final question to be considered is whether these theoretical proposals
provide any indication that the process of hydroxylation is associated with the
carcinogenic response elicited by certain hydrocarbons. If the non-carcinogenic
members of this series do in fact undergo hydroxylation when in an unbound
state then an obvious conclusion is that it is the binding, either ortho or para,
of the carcinogens which is a contributing factor in carcinogenesis. If, however,
the non-carcinogens are first subjected to binding prior to hydroxylation then,
as theoretical considerations suggest that this occurs at the reactive bond rather
than across the reactive positions, this would appear to exclude the ortho form
of binding from the carcinogenic mechanism. Furthermore, the proposal that
species differences in metabolism between the rabbit and rat and mouse
respectively may be attributed to the greater contribution of ortho binding in
the former species is inversely paralleled by the susceptibility of these species
towards the induction of carcinogenesis by the hydrocarbons. 1: 2: 5: 6-
Dibenzanthracene, for example, is a potent carcinogen for the rat and mouse but
is without activity in the rabbit. If the theory is correct, therefore, there would
appear to be no association between the ortho or K-region binding of hydroxyla-
tion and carcinogenesis. It is tempting to speculate then that the para form of
binding may be an important factor governing the carcinogenic response and
certain evidence may be cited in support of this view. Thus the blocking of
the para-positions in compounds such as cis-9: 10-dimethyl-9: 10-dihydro-
1: 2: 5: 6-dibenzanthracene and 9: 10-dimethyl-1: 2-benzanthracene-a, ,-endo-
succine acid is accompanied by a marked reduction in the carcinogenic potencies
of the parent hydrocarbons from which these are derived. Such behaviour may
be interpreted as an indication that substitution in the meso-positions of these
hydrocarbons prevents the process of para-binding during hydroxylation. Also,
9: 10-dimethyl-1: 2-benzanthracene is considerably more carcinogenic than is
the parent 1: 2-benzanthracene and this behaviour is reflected in the reactivities
of these compounds towards the para-addition of maleic anhydride, this occurring
more readily with the dimethyl derivative (Bachmann and Chemerda, 1938;
Newman and Otsuka, 1959). In other words the effect of methyl substitution
in the 9: 10-positions of 1: 2-benzanthracene, and indeed in those of anthracene,
is to facilitate the process ofpara-addition at these points. In this case, however,
we are dealing with a specific type of cyclic dienophile addition and it is not
surprising therefore that the analogy breaks down when applied to the whole
range of polycyclic hydrocarbons. What is envisaged biologically rather is an
addition type of complex arising from combination of the carcinogen either with
two molecules or with distal groups of the same molecule so that it constitutes
in effect a cross linkage between the two. As was stated earlier the exact mode
of linkage is as yet unknown. Boyland (1950a) has suggested a simple covalent
type of addition whilst Pullman and Pullman (1955) prefer the quinonoidal type
of linkage. A third type of addition not yet considered, however, is that of
co-ordination. The latter phenomenon was investigated by Kofahl and Lucas
(1954) who reported a fair degree of correlation between the carcinogenic
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potencies of aromatic hydrocarbons and their co-ordination activity towards
silver ion in the argentation reaction. Complex formation with iodine ions has
also been observed (Benesi and Hildebrand, 1948) and the solubilising effect of
purine derivatives upon the polycyclic hydrocarbons (Weil-Malherbe, 1946) is
now well known. Is it not possible therefore that similar co-ordination complexes
may be formed between the hydrocarbon and say the ionised groups of an
enzyme within the microsomes? The process of hydroxylation may then be
regarded as a neutralisation of the electronic charge resident on the hydrocarbon
portion of the complex resulting in the formation of a phenol and consequent
liberation of the enzyme.
If, as the evidence suggests, the mechanism of hydroxylation is associated
with the carcinogenic mechanism, then the origin of this cellular malformation
must reside within the microsomes. Furthermore, as the hydroxylating
activity ofthe microsomes was found by Conney et al. (1957) to remain unchanged
after preincubation with ribonuclease, the field of action may be narrowed down
still further to the non-ribonucleic acid fraction of these organelles. It is
significant therefore that Fiala and Fiala (1959) have concluded on entirely
different grounds that the non-ribonucleoprotein fraction of the ergastoplasm is
the origin of the hepatic carcinogenic response elicited by azo dyes.
The suggestion, however, that there may be an association between a para
form of binding and carcinogenesis is in conflict with certain experimental
evidence on this subject.
The hydrocarbon 1: 2: 3: 4-dibenzanthracene for example, does not possess
a K-region as such and yet undergoes extensive binding to protein within the
skin (Heidelberger and Moldenhauer, 1956). The logical explanation of this
behaviour is that binding occurs at the reactive meso-positions of the molecule
and yet this hydrocarbon is, at most, a very weak carcinogen. Also, the
evidence reported by Oliverio and Heidelberger (1958) in support ofa relationship
between K-region binding and carcinogenic activity in the 1: 2: 5: 6-dibenz-
anthracene series is most convincing although not without certain anomalies.
What is possible, however, is that we are dealing with two different and
possibly independent processes, one concerned with overall binding to cellular
protein and the other with binding, possibly to enzymes, within the microsomes
where the hydroxylating system is active. There is in fact evidence that two
such forms of binding may exist, for it was found by Miller (1951) that, although
normal alkaline hydrolysis was effective in liberating a fluorescent acidic deriva-
tive from the precipitated protein of skin following treatment with 3: 4-
benzpyrene, a further fluorescent neutral fraction was only released by this
procedure when zinc dust was present in the mixture. Significantly the former
conditions are also those necessary for the quantitative liberation of 3: 4-
benzpyrene from the microsomal system of hydroxylation (Conney et al., 1957).
On existing evidence the K-region binding theory of carcinogenesis must
obviously be favoured for this phenomenon has been demonstrated within the
skin where tumour formation occurs. The microsomal system of hydroxylation
on the other hand has so far been detected only within the liver where the
induction ofhepatoma formation by polycyclic aromatic hydrocarbons is open to
doubt. More must be known therefore of the enzymatic system ofhydroxylation
within the skin and the mechanisms involved before this apparent conflict can be
resolved. It is then possible that studies of binding in the in vitro systems may
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provide a truer picture of in vivo behaviour for, as the hydrocarbon is not added
until the processes of cellular disintegration and centrifugation have been carried
out, the objections raised by Hadler, Darchun and Lee (1959) no longer apply.
Except where stated the chemical data referred to in this work are taken either
from Fieser and Fieser (1944), Gilman's 'Organic Chemistry' (1947) or Elsevier's
' Encyclopaedia of Organic Chemistry ', Supplementary Volume 14 (1951).
Data of carcinogenic activity are taken from Hartwell (1951).
SUMMARY
A theory involving linkage to cellular material, possibly enzymes, within
the microsomes has been developed to account for the fact that carcinogenic
hydrocarbons undergo hydroxylation principally at positions of the molecule
which are inert to chemical attack. It is postulated that binding may occur
either across non-adjacent reactive positions or at the reactive bond each of
which leads to activation at different sites of the molecule. On this reasoning
it is concluded that species differences in the site of hydroxylation are due to
differences in the relative contributions of these distinct forms of binding to
the total amount bound in any one species. An ortho form of binding would
appear to be favoured in the rabbit and a para form in the rat and mouse.
The hydroxylation of non-carcinogenic hydrocarbons on the other hand is
best explained either on the basis of non-binding or of binding through the
most reactive bond. There would thus appear to be no association between
an ortho form of binding during hydroxylation and carcinogenesis. It follows
therefore that a para form of binding may be of importance in this respect and
this possibility is discussed in relation to current views on protein binding and
carcinogenesis.
The expenses of this work were defrayed from a block grant by the British
Empire Cancer Campaign.
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